VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,671 | -10.6% | 1,883 | 0.0% | 0.01% | -11.1% |
| Q2 2023 | $56,697 | -6.9% | 1,883 | 0.0% | 0.01% | -10.0% |
| Q1 2023 | $60,915 | +12.9% | 1,883 | 0.0% | 0.01% | +11.1% |
| Q4 2022 | $53,966 | -99.9% | 1,883 | 0.0% | 0.01% | +12.5% |
| Q3 2022 | $45,417,000 | -11.9% | 1,883 | 0.0% | 0.01% | -11.1% |
| Q2 2022 | $51,556,000 | -28.6% | 1,883 | 0.0% | 0.01% | -18.2% |
| Q1 2022 | $72,213,000 | +19.7% | 1,883 | 0.0% | 0.01% | +22.2% |
| Q4 2021 | $60,312,000 | +8.7% | 1,883 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $55,492,000 | -13.3% | 1,883 | 0.0% | 0.01% | -18.2% |
| Q2 2021 | $63,984,000 | +4.6% | 1,883 | 0.0% | 0.01% | -8.3% |
| Q1 2021 | $61,197,000 | -9.8% | 1,883 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $67,825,000 | -13.3% | 1,883 | -11.7% | 0.01% | -22.2% |
| Q2 2020 | $78,238,000 | -75.0% | 2,133 | -84.3% | 0.02% | -80.6% |
| Q1 2020 | $313,528,000 | – | 13,608 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |